XSHE
002783
Market cap597mUSD
Oct 09, Last price
8.08CNY
1D
0.87%
1Q
14.61%
Jan 2017
-61.27%
IPO
-28.87%
Name
Hubei Kailong Chemical Group Co Ltd
Chart & performance
P/E
28.33
P/S
1.14
EPS
0.29
Div yield, %
1.25%
Shrs. gr., 5y
5.52%
Rev. gr., 5y
5.13%
Revenues
3.54b
-3.85%
Net income
142m
-3.87%
CFO
516m
+28.34%
Dividend
Jun 11, 20260.1 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hubei Kailong Chemical Group Co., Ltd. is a Chinese enterprise primarily engaged in the manufacturing and distribution of explosive materials. Its diverse product portfolio encompasses industrial explosives, nanoscale calcium carbonate, nitro-compound fertilizers, and ammonium nitrate, alongside paper-plastic packaging solutions. The company further extends its operations into providing specialized engineering blasting services. Established in 1967, Hubei Kailong Chemical Group is headquartered in Jingmen, China.
Key people
Jie Sun
General Counsel, Secretary of the Board · since 2025
Feng Shao
General Manager · since 2025
Songhua Li
Deputy General Manager · since 2001
Zhe Liu
Deputy General Manager · since 2025
Weidong Lu
Deputy General Manager · since 2025
Yong Zhang
Finance Director, Deputy General Manager · since 2012
Xuejun Han
Chief Engineer · since 2025
Jiabing Li
Chief Safety Officer · since 2025
Wenxue Gao
Director · since 2025
Yan Hu
Director · since 2025
Xuerui Jiang
Chief Financial Officer, Staff Elected Director · since 2025
Shihua Luo
Director · since 2025
Xingxiang Shao
Chairman of the Board · since 2001
Junshan Tu
Director · since 2025
Ping Wang
Director · since 2025
Xiaolin Yao
Director · since 2025
Independent Director
Headquarters & legal address
湖北省荆门市东宝区泉口路20号
荆门市, HB 100000
CN
荆门市, HB 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2020‑00 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||||
Revenues | |||||||||||||
Cost of revenue | |||||||||||||
Unusual Expense (Income) | |||||||||||||
NOPBT | |||||||||||||
NOPBT Margin | |||||||||||||
Operating Taxes | |||||||||||||
Tax Rate | |||||||||||||
NOPAT | |||||||||||||
Net income | |||||||||||||
Dividends | |||||||||||||
Dividend yield | |||||||||||||
Proceeds from repurchase of equity | |||||||||||||
BB yield | |||||||||||||
| Debt | |||||||||||||
Debt current | |||||||||||||
Long-term debt | |||||||||||||
Deferred revenue | |||||||||||||
Other long-term liabilities | |||||||||||||
Net debt | |||||||||||||
| Cash flow | |||||||||||||
Cash from operating activities | |||||||||||||
CAPEX | |||||||||||||
Cash from investing activities | |||||||||||||
Cash from financing activities | |||||||||||||
FCF | |||||||||||||
| Balance | |||||||||||||
Cash | |||||||||||||
Long term investments | |||||||||||||
Excess cash | |||||||||||||
Stockholders' equity | |||||||||||||
Invested Capital | |||||||||||||
ROIC | |||||||||||||
ROCE | |||||||||||||
| EV | |||||||||||||
Common stock shares outstanding | |||||||||||||
Price | |||||||||||||
Market cap | |||||||||||||
EV | |||||||||||||
EBITDA | |||||||||||||
EV/EBITDA | |||||||||||||
Interest | |||||||||||||
Interest/NOPBT | |||||||||||||